NCT06401785View on ClinicalTrials.gov

To Evaluate the Efficacy of Oral Molecular Hydrogen Supplement in Patients With Chronic Diseases

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 11, 2024

Primary Completion Date

December 29, 2024

Study Completion Date

January 29, 2025

Conditions
Chronic DiseaseChronic Inflammation
Interventions
DIETARY_SUPPLEMENT

Hydrogen capsules

In experiment group, participants will receive 2 solid hydrogen capsules every day for 24 weeks. In control group, participants will receive 2 capsules not containing hydrogen every day for 24 weeks.

Trial Locations (2)

Unknown

RECRUITING

Tri-Service General Hospital, Taipei

RECRUITING

Taoyuan Armed Forces General Hospital, Taoyuan District

Sponsors

Lead Sponsor

HoHo Biotech
All Listed Sponsors
collaborator

Taoyuan Armed Forces General Hospital

UNKNOWN

collaborator

Tri-Service General Hospital

OTHER

lead

HoHo Biotech

INDUSTRY